Post by Genmab
168,829 followers
#NewsUpdate: The European Commission has granted marketing authorization for one of our #BloodCancer therapies, developed in partnership with AbbVie, as a combination regimen for adult patients with relapsed/refractory (R/R) follicular #lymphoma (FL). Learn more: http://gmab.ly/qR9L50ZaGpR
Video Content